MedPage Today on MSN
PSMA-PET cuts need for biopsy in suspected prostate cancer
But does it cost too much?
Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential ...
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
Prostate Biopsy Findings. PROSTATE biopsy under local anesthesia showed similar safety and detection outcomes, with better ...
Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results